-Advertisement-
-Advertisement-
Lupus Nephritis
Renal mTOR a potential clinical biomarker in lupus nephritis
A new study found that mammalian target of rapamycin (mTOR) activation is a potential biomarker of disease activity and may help predict clinical prognosis in patients with lupus nephritis (LN)/ In the retrospective study, renal biopsies from 187 patients with LN, 20 patients with diabetic nephropathy (DN), 10 patients with minimal...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
Quizzes
-Advertisement-
Contact
© 2025 Med Journal 360® is a trademark of International Healthcare Media, LLC. All rights Reserved